Preclinical and clinical evaluation of Buparlisib (BKM120) in recurrent/refractory Central Nervous System Lymphoma-Reference-Cited by-同舟云学术

Preclinical and clinical evaluation of Buparlisib (BKM120) in recurrent/refractory Central Nervous System Lymphoma

Published:2023-06-15 Issue:9 Volume:64 Page:1545-1553
ISSN:1042-8194
Container-title:Leukemia & Lymphoma
language:en
Short-container-title:Leukemia & Lymphoma

Author:

Grommes Christian¹²³^ORCID,Pentsova Elena¹³^ORCID,Schaff Lauren R.¹³^ORCID,Nolan Craig P.¹³^ORCID,Kaley Thomas¹³^ORCID,Reiner Anne S.⁴^ORCID,Panageas Katherine S.⁴^ORCID,Mellinghoff Ingo K.¹²³^ORCID

Affiliation:

1. Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, NY, USA

2. Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA

3. Department of Neurology, Weill Cornell Medical College, New York, NY, USA

4. Department of Epidemiology & Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA

Funder

National Institutes of Health

Memorial Sloan Kettering Brain Tumor Center

Society of Memorial Sloan Kettering Cancer Center

American Brain Tumor Association Basic Research Fellowship Award

Lymphoma Research Foundation

Susan and Peter Solomon Divisional Fund

Cycle for Survival

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,Hematology

Link

https://www.tandfonline.com/doi/pdf/10.1080/10428194.2023.2223734

Reference32 articles.

1. Treatment of primary central nervous system lymphoma

2. Therapeutic challenges in primary CNS lymphoma

3. An Update on Therapy of Primary Central Nervous System Lymphoma

4. Metastatic neurologic complications of non-Hodgkin’s lymphoma

5. How I treat primary CNS lymphoma

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Molecular oncobiology and cancer chemotherapeutics;Biochemical and Molecular Pharmacology in Drug Discovery;2024

2. Neue Therapiestrategien beim primären Lymphom des Zentralnervensystems;Der Nervenarzt;2023-11-01

3. Extranodal lymphoma: pathogenesis, diagnosis and treatment;Molecular Biomedicine;2023-09-18